FDA Drug Application (021632) for ERAXIS by VICURON

Back to FDA Applications sponsored by VICURON

Application Number021632
Product Number001
FormINJECTABLE;IV (INFUSION)
Dosage50MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameERAXIS
Active IngredientANIDULAFUNGIN



Back to FDA Applications sponsored by VICURON